ENV-101 (taladegib)

taladegib · Endeavor Biomedicines, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ENV-101 (taladegib), covering 2026-03-06 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1, Open-Label Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants [Phase 1]

See pricing